Literature DB >> 19946951

Determination of benzalkonium chloride in viscous ophthalmic drops of azithromycin by high-performance liquid chromatography.

Yan Shen1, Sheng-jie Xu, Shi-chun Wang, Jia-sheng Tu.   

Abstract

A high-performance liquid chromatography (HPLC) system was used in the reversed phase mode for the determination of benzalkonium chloride (BKC) in azithromycin viscous ophthalmic drops. A Venusil-XBP(L)-C(18) (150 mmx4.6 mm, 5 microm) column was used at 50 degrees C. The mobile phase consisted of a mixture of methanol-potassium phosphate (16:5, v/v). Two sample preparation methods were compared. The results suggested that, compared with an extraction procedure, a deproteinization procedure was much quicker and more convenient. Using the deproteinization procedure for sample preparation, calibration curves were linear in the range 5.0 to approximately 50 microg/ml. The within-day and inter-day coefficients of variation were less than 10%. The average recoveries were determined as 96.70%, 98.52%, and 97.96% at concentrations of 10.0, 30.0, and 50.0 microg/ml, respectively. Variability in precision did not exceed 5%. In conclusion, this HPLC method using a simple sample treatment procedure appears suitable for monitoring BKC content in azithromycin viscous ophthalmic drops.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946951      PMCID: PMC2789522          DOI: 10.1631/jzus.B0920229

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  14 in total

1.  Development and validation of a capillary zone electrophoresis method for the determination of benzalkonium chlorides in ophthalmic solutions.

Authors:  Ya-Hui Hou; Chien-Yi Wu; Wang-Hsien Ding
Journal:  J Chromatogr A       Date:  2002-11-08       Impact factor: 4.759

2.  Rapid determination of total benzalkonium chloride content in ophthalmic formulation.

Authors:  Louis-Philippe Labranche; Suzanne N Dumont; Suzanne Levesque; Alain Carrier
Journal:  J Pharm Biomed Anal       Date:  2006-10-12       Impact factor: 3.935

3.  Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices.

Authors:  Aditya S Tatavarti; Stephen W Hoag
Journal:  J Pharm Sci       Date:  2006-07       Impact factor: 3.534

4.  Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.

Authors:  Pasquale Aragona; Vincenzo Papa; Antonio Micali; Marcello Santocono; Giovanni Milazzo
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

5.  Quantitation of active ingredients and excipients in nasal sprays by high-performance liquid chromatography, capillary electrophoresis and UV spectroscopy.

Authors:  J L Bernal; M J del Nozal; M T Martín; J C Diez-Masa; A Cifuentes
Journal:  J Chromatogr A       Date:  1998-10-09       Impact factor: 4.759

6.  Simple HPLC determination of benzalkonium chloride in ophthalmic formulations containing antazoline and tetrahydrozoline.

Authors:  Pornchai Rojsitthisak; Wisut Wichitnithad; Ongart Pipitharome; Kingkan Sanphanya; Peeracha Thanawattanawanich
Journal:  PDA J Pharm Sci Technol       Date:  2005 Sep-Oct

7.  Analysis of benzalkonium chloride and its homologs: HPLC versus HPCE.

Authors:  S J Prince; H J McLaury; L V Allen; P McLaury
Journal:  J Pharm Biomed Anal       Date:  1999-05       Impact factor: 3.935

8.  Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time.

Authors:  Young Bin Choy; Jung-Hwan Park; Bernard E McCarey; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

9.  Rheological study of binary gels with Carbopol Ultrez 10 and hyaluronic acid.

Authors:  María Magdalena Jiménez; María José Fresno; Alain Ramírez
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-08       Impact factor: 1.645

10.  Ophthalmic azithromycin (AzaSite).

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2008-02-11       Impact factor: 1.909

View more
  1 in total

1.  Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.

Authors:  C Vijaya; K Swetha Goud
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.